Is there a better way? Bioethical reflections on palliative cytotoxic drug use

Palliative Medicine

Volumn 9, Issue 4, 1995, Pages 269-271

  McGrath, Pam ^a   Kearsley, J H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT;

CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; DRUG USE; EDITORIAL; HUMAN; MEDICAL ETHICS;

ANTINEOPLASTIC AGENTS; DECISION MAKING; ETHICS, MEDICAL; HUMAN; NEOPLASMS; PALLIATIVE CARE; QUALITY OF LIFE;

EID: 0028851725     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/026921639500900401     Document Type: Editorial

References (5)

1. Stoll BA Balancing cost and benefit in treatment of late cancer. Lancet 1988; i: 579-80.
2. Weissmann E., O'Donnell J., Brady A. A cry from the fringe [Letter]. J Clin Oncol 1993; 11: 1006.
3. Kearsley JH Wanted: guidelines for ‘palliative’ anticancer drug use. Med J Aust 1994; 160: 723-25.
4. Slevin ML, Stubb L., Plant HJ et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses and general public. Br Med J 1990; 300: 1458-60.
5. Spiegel D., Bloom JR, Kraemer H., Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; ii: 1888-91.